Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.11.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ER.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.6.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DB.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.26.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Q.4 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used